BIOGENED
Research BIOGENED (BGD.WA) on Bullrun: market cap PLN 48.39M, P/E 10.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBGD.WA
- ExchangeXNCO
- CountryPoland
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyPLN
- Market capPLN 48.39M
- P/E10.1
- Financial periodQ1 2026
- RevenuePLN 28.30M
- Net incomePLN 2.56M
- Free cash flow-PLN 265.13K
- Gross margin67.2%
Valuation Snapshot
latest market cap is PLN 48.39M; P/E is 10.1.
Peer valuation comparison
Latest P/E is 10.1x versus a Healthcare sector median of 24.61x (58.9% below).
Latest P/E is 10.1x versus a Poland median of 12.32x (18.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | PLN 114.04M | PLN 4.62M | PLN 5.13M | 64.0% | 1.88 | PLN 6.32M | PLN 23.04M | PLN 45.02M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | PLN 48.39M | 10.1 | 2.5% | 0.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.5 PLN.
About BIOGENED
Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand, as well as thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BIOGENED's market cap?
BIOGENED's market capitalization is PLN 48.39M.
What is BIOGENED's P/E ratio?
BIOGENED's price-to-earnings (P/E) ratio is 10.1.
What does BIOGENED do?
Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand, as well as thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland.